The Power of Music & Movement
“Music has the power to transcend borders, cultures and languages to connect people… Now, with MedRhythms, we’re seeing the power of music harnessed to heal.” — Michael Nash, Executive VP of Digital Strategy, Universal Music Group
MedRhythms has developed the world’s first prescription music neurorehabilitation platform, improving walking through Rx-only, home-use medical devices. When the brain perceives rhythm, the auditory and motor systems (that facilitate walking) can sync to the beat. MedRhythms’ use-at-home devices harness this link to support gait rehabilitation by delivering individualized, progressive rhythmic auditory stimulation (RAS). RAS is backed by 30+ years of research. MedRhythms products ship directly to the patient with everything needed in the box: wearable, clinical-grade gait sensors, a touchscreen control unit containing adaptive algorithms and clinically optimized music, and a bone-conducting headset.
MOVIVE provides therapeutically delivered music based on the latest neuroscience research. It is indicated to support gait rehabilitation and motor recovery in home for people living with Parkinson Disease (PD).
“MOVIVE delivers rhythmic auditory stimulation (RAS) to individuals with Parkinson’s disease in the home using both familiar and newly discovered music across a variety of genres. Impressively, PD participants increased, on average, their daily step count by 28% and their moderate intensity activity by 56% from baseline. A typical PD patient decreases significantly on both of these measures over the course of their disease.” – Dr. Alexander Pantelyat, Co-Founder and Director of the Johns Hopkins Center for Music and Medicine, and Co-Principal Investigator of the MOVIVE feasibility study (Zajac et al., 2023) v20262.1
MOVIVE Research Update: Boston University (BU) has been awarded a $2 million research grant from The Michael J. Fox Foundation (MJFF) for Parkinson’s Research . The funding will support a clinical study evaluating motor and cognitive factors associated with changes in walking for people with Parkinson’s disease who use MedRhythms’ MOVIVE™ (MR-005).



